eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | c syndrome |
| Comorbidity | |liver disease |
| Sentences | 64 |
| PubMedID- 24280560 | Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. |
| PubMedID- 24665862 | Management of fatty liver disease with the metabolic syndrome. |
| PubMedID- 24531850 | Evolving information suggests that the metabolic syndrome with non-alcoholic liver disease may be an important cause of hcc in addition to viral hepatitis and alcohol-induced liver disease. |
| PubMedID- 25738756 | Moreover, metabolic syndrome is intricately associated with non-alcoholic fatty liver disease [2]. |
| PubMedID- 25926979 | The presence of multiple features of the metabolic syndrome is associated with progressive liver disease [53]. |
| PubMedID- 25881985 | liver diseases lead to a complex syndrome characterized by neurological, neuro-psychiatric and motor complications, called hepatic encephalopathy, which is prevalent in patients and animal models of acute, sub-chronic and chronic liver failure. |
| PubMedID- 22912746 | Hepatic encephalopathy (he) is a neuropsychiatric syndrome that develops in patients with severe liver diseases and/or portosystemic shunting (ps) resulted from serious complication of acute and chronic liver failure. |
| PubMedID- 21212755 | Nonalcoholic fatty liver disease is associated with the metabolic syndrome. |
| PubMedID- 26494427 | Recent studies have shown comparable procedure-related complications and long-term survival in patients who undergo transjugular intrahepatic portosystemic shunting and liver transplantation in budd-chiari syndrome compared with other liver disease aetiologies. |
| PubMedID- 20158939 | Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. |
| PubMedID- 20817302 | Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome. |
| PubMedID- 24793377 | In conclusion, in contrast to bpa, bps does not appear to induce the metabolic syndrome that may lead to non-alcoholic fatty liver disease (nafld), in vitro. |
| PubMedID- 22135029 | It is important to analyse the morphologic spectrum of bile duct changes in non-biliary diseases as a link has been reported between intrahepatic cholangiocarcinoma and chronic liver disease associated with viral hepatitis, metabolic syndromes and with alcohol abuse. |
| PubMedID- 24000461 | [strengthen the research and management of the relationship of liver diseases with metabolic syndrome]. |
Page: 1 2